MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2025 International Congress

    Seed amplification assay detects alpha-synuclein in cerebrospinal fluid in pre- and symptomatic autosomal dominant Alzheimer’s disease

    A. Ahuja, J. Ringman, K. Wong (Los Angeles, USA)

    Objective: To examine the ability to detect concurrent Lewy Body Disease via Lew Body pathology (LBP) in Autosomal Dominant Alzheimer’s Disease (ADAD) through detection of…
  • 2025 International Congress

    Demographic Characteristics of Women with Primary Parkinsonism

    E. Tharp, J. Martinez-Lemus, J. Suescun, M. Schiess (Houston, USA)

    Objective: To assess the demographic profile and other health characteristics of women with primary parkinsonism who present to the Texas Medical Center for care. Background:…
  • 2025 International Congress

    Efficacy of Stimulant Use for Cognitive Fluctuations in Lewy Body Dementia: A Case Study

    L. Lopez, A. Petrov, Z. Afshari (Glenview, USA)

    Objective: To evaluate the effectiveness of stimulants in reducing cognitive fluctuations in Lewy Body Dementia (LBD). Background: Lewy Body Dementia (LBD) is the 2nd most…
  • 2025 International Congress

    Identifying Cut-off Values, Effects of AD Co-pathology, Sex Differences, and Temporal Changes of 123I-FP-CIT SPECT in Autopsy-proven LBD

    T. Miyagawa, S. Przybelski, C. Cynthia, HK. Minmin, L. Forsberg, J. Fields, S. Mccarter, T. Ferman, V. Ramanan, J. Graff-Radford, D. Jones, R. Savica, D. Knopman, R. Petersen, R. Reichard, A. Nguyen, D. Dickson, M. Murray, G. Day, N. Graff-Radford, C. Lachner, E. St Louis, M. Jain, K. Kantarci, V. Lowe, B. Boeve (ROCHESTER, USA)

    Objective: We analyzed autopsy-proven Lewy body disease (LBD) and/or Alzheimer’s disease (AD) dementia patients with 123I-FP-CIT SPECT to investigate previously unclarified detailed aspects of 123I-FP-CIT…
  • 2025 International Congress

    Stepping backwards to move forward A case study on novel PT interventions for DLB

    K. Vasher, A. Boddy (Loma Linda, USA)

    Objective: Explore the effectiveness of backwards walking and backwards stepping interventions to improve gait stability and balance in persons with Dementia with Lewy Bodies (DLB).…
  • 2025 International Congress

    Association of Mitochondrial DNA Haplogroup and pS65-Ub Levels in Lewy Body Disease

    N. Tran, X. Hou, M. Heckman, F. Fiesel, S. Koga, D. Dickson, W. Springer, O. Ross (Jacksonville, USA)

    Objective: To determine whether specific mitochondrial DNA (mtDNA) haplogroup(s) affect the level of p-S65-Ub as quantitative marker of mitochondrial damage in Lewy Body Disease. Background:…
  • 2024 International Congress

    Association of β-Amyloid Load on PET with Cognitive Profiles Across the Lewy Body Diseases Continuum

    KA. Woo, EJ. Yoon, SY. Kim, HJ. Kim, BR. Jin, SM. Lee, HW. Nam, HW. Park, YK. Kim, JY. Lee (Seoul, Republic of Korea)

    Objective: To investigate the association between Aβ accumulation and clinical characteristics across the Lewy body disease (LBD) spectrum, with a specific focus on global and…
  • 2024 International Congress

    Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies

    I. Rektorova, Z. Zeleznikova, L. Brabenec, K. Mitterova, L. Novakova (Brno, Czech Republic)

    Objective: To evaluate NMS signal changes in the locus coeruleus (LC) in mild cognitive impairment with Lewy bodies (MCI-LB) as compared to healthy controls (HC)…
  • 2024 International Congress

    Prediction of Time-to-Phenoconversion to Parkinsonism in Idiopathic REM Sleep Behavior Disorder (iRBD)

    SM. Fereshtehnejad, A. Delva, Y. Zeighami, M. Dadar, A. Pelletier, J. Montplaisir, JF. Gagnon, C. Marras, R. Postuma (Toronto, Canada)

    Objective: To develop a tool for the prediction of time-to-phenoconversion in individuals with iRBD during the prodromal stage of parkinsonism. Background: Parkinson’s disease(PD) and dementia…
  • 2024 International Congress

    Common Genetic Variation Associated with Parkinson’s Disease Biological Measures

    EN. Somerville, K. Senkevich, M. Ta, E. Yu, H. Iwaki, Z. Gan-Or (Montreal, Canada)

    Objective: To identify common genetic variants associated with biological measures that have been implicated in Parkinson’s disease and related synucleinopathies. Background: Alpha synucleinopathies, mainly including…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 25
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley